BAXTER INTERNATIONAL INC. Funds and ETFs Baxter International Inc.
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.69 USD | -0.72% |
|
-3.25% | -7.68% |
| May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
| May. 09 | Declaration of Voting Results by Baxter International Inc | CI |
ETFs positioned on Baxter International Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 13.07% | 0 M€ | +12.39% | - | |
| 1.23% | 0 M€ | +6.39% | - | |
| 0.81% | 4 M€ | +20.15% | ||
| 0.75% | 0 M€ | +4.88% | ||
| 0.73% | 0 M€ | +9.27% | ||
| 0.40% | 9 M€ | -.--% | - | |
| 0.38% | 1 M€ | +2.21% | - | |
| 0.24% | 5 M€ | -72.95% | - | |
| 0.19% | 0 M€ | +12.85% | ||
| 0.19% | 7 M€ | +0.11% | - | |
| 0.16% | 0 M€ | +8.67% | ||
| 0.15% | 0 M€ | +8.70% | ||
| 0.15% | 0 M€ | +4.60% | - | |
| 0.14% | 0 M€ | -.--% | - | |
| 0.13% | 0 M€ | -.--% | - | |
| 0.13% | 0 M€ | +9.15% | - | |
| 0.13% | 0 M€ | +11.72% | ||
| 0.13% | 219 M€ | +17.17% | - | |
| 0.13% | 1,448 M€ | -.--% | - | |
| 0.12% | 330 M€ | -.--% | ||
| 0.11% | 0 M€ | +8.06% | ||
| 0.11% | 0 M€ | +18.44% | - | |
| 0.10% | 26 M€ | +16.85% | - |
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows:
- medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.);
- kidney dialysis drugs and equipment (30.1%);
- systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.;
- other (20.1%).
Export accounts for 52.7% of net sales.
Calendar
2024-05-15
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
35.69
USD
Average target price
46.47
USD
Spread / Average Target
+30.20%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.68% | 18.19B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.81% | 40.7B | |
| +24.51% | 32.3B | |
| +3.43% | 26.53B | |
| +14.19% | 25.02B |
- Stock Market
- Equities
- BAX Stock
- Funds and ETFs Baxter International Inc.
